Share chart Catalyst Pharmaceuticals, Inc.
Extended chart
Simple chart
About Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc., коммерческая биофармацевтическая компания, занимается разработкой и коммерциализацией методов лечения людей с редкими инвалидизирующими, хроническими нервно-мышечными и неврологическими заболеваниями в Соединенных Штатах. Он предлагает Firdapse, таблетки фосфата амифампридина для лечения пациентов с миастеническим синдромом Ламберта-Итона (LEMS); и Ruzurgi для лечения педиатрических пациентов с LEMS. Компания разрабатывает Firdapse для лечения миастении с положительной реакцией на антитела к MuSK и типа спинальной мышечной атрофии. more detailsIPO date | 2006-11-08 |
---|---|
ISIN | US14888U1016 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.catalystpharma.com |
Цена ао | 20.87 |
Change price per day: | 0% (20.87) |
---|---|
Change price per week: | -4.96% (21.96) |
Change price per month: | -8.06% (22.7) |
Change price per 3 month: | -2.39% (21.38) |
Change price per half year: | +2.1% (20.44) |
Change price per year: | +29.87% (16.07) |
Change price per 3 year: | +175.33% (7.58) |
Change price per 5 year: | +306.82% (5.13) |
Change price per 10 year: | 0% (20.87) |
Change price per year to date: | -3.47% (21.62) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Steven R. Miller Ph.D. | Executive VP, COO & Chief Scientific Officer | 809.03k | 1962 (63 years) |
Dr. Gary Ingenito M.D., Ph.D. | Chief Medical & Regulatory Officer | 751.85k | 1956 (69 years) |
Mr. Jeffrey Del Carmen | Executive VP & Chief Commercial Officer | 711.7k | 1971 (54 years) |
Ms. Mary Coleman | VP & Head of Investor Relations | N/A | |
Mr. Brian Elsbernd J.D. | Chief Compliance Officer & Chief Legal Officer | 311.42k | 1964 (61 year) |
Mr. Pete Curry Sr. | Vice President of Sales | N/A | |
Dr. Stanley Iyadurai M.D., Ph.D. | Senior Vice President of Medical Affairs & Drug Discovery | N/A | |
Mr. Richard John Daly M.B.A. | President, CEO & Director | 63.12k | 1961 (64 years) |
Mr. Michael W. Kalb CPA | Executive VP, Treasurer & CFO | N/A | 1971 (54 years) |
Dr. Preethi Sundaram Ph.D. | Chief Strategy Officer | 1976 (49 years) |
Address: United States, Coral Gables. FL, 355 Alhambra Circle - open in Google maps, open in Yandex maps
Website: https://www.catalystpharma.com
Website: https://www.catalystpharma.com